With high theoretical energy density, rechargeable metal–gas batteries (e.g., Li–CO2 battery) are considered as one of the most promising energy storage devices. However, their practical applications are hindered by the sluggish reaction kinetics and discharge product accumulation during battery cycling. Currently, the solutions focus on exploration of new catalysts while the thorough understanding of their underlying mechanisms is often ignored. Herein, the interfacial electronic interaction within rationally designed catalysts, ZnS quantum dots/nitrogen‐doped reduced graphene oxide (ZnS QDs/N‐rGO) heterostructures, and their effects on transformation and deposition of discharge products in the Li–CO2 battery are revealed. In this work, the interfacial interaction can both enhance the catalytic activities of ZnS QDs/N‐rGO heterostructures and induce the nucleation of discharge products to form a homogeneous Li2CO3/C film with excellent electronic transmission and high electrochemical activities. When the batteries cycle within a cutoff specific capacity of 1000 mAh g−1 at a current density of 400 mA g−1, the cycling performance of the Li–CO2 battery using a ZnS QDs/N‐rGO cathode is over 3 and 9 times than those coupled with a ZnS nanosheets (NST)/N‐rGO cathode and a N‐rGO cathode, respectively. This work provides comprehensive understandings on designing catalysts for Li–CO2 batteries as well as other rechargeable metal–gas batteries.
A brand new polysulfide entrapping strategy based on the ferroelectric effect has been demonstrated for the first time. By simply adding the nano-ferroelectrics (BaTiO nanoparticles) into the cathode, the heteropolar polysulfides can be anchored within the cathode due to the internal electric field originated from the spontaneous polarization BaTiO nanoparticles, and thus significantly improving the cycle stability of Li-S batteries.
Various therapeutic interventions have been studied and found to be effective in reducing the stereotypical behaviors of children with autism spectrum disorder (ASD). There has been increasing interest in using animal-assisted interventions (AAIs) as an alternative approach to therapeutic rehabilitation for children with ASD, and many studies have reported that AAI has significant benefits for the cognitive, psychological, and social behavior of children with ASD. The present study was designed to examine the effects of a 16 weeks therapeutic horseback riding program on social interaction and communication skills in children with autism. Eighty-four children diagnosed with ASD, aged between 6 and 12 years old, were recruited for this study. All selected participants met the DSM-V criteria, and a total of sixty-one participants (N = 61) completed the study. A quasi-experimental design with an experimental group and control group was implemented for this study, taking measurements at pre-test, interim-test, and post-test to monitor the behavior changes in social and communication throughout the 16-week intervention. Repeated measures ANOVA and the independent sample t-test were used for data analysis, to assess the difference between the experimental group and control group. The results indicated that the THR program had positive influences on overall social skills and communication, based on the SSIS and the ABLLS-R scores, compared to the control group (p < 0.05). A notable improvement in the overall social interaction score was observed from the interim-testing point to post-test. In addition, participants in the therapeutic horseback riding (THR) group achieved significant improvements on six out of seven items in their communication evaluations. In conclusion, after 16 weeks of intervention, the THR program significantly enhanced the subdomains of social and communication skills in the areas of social interaction, communication, responsibility, and self-control, compared to the control group.
An intramolecular transacylation reaction was observed in the mass spectrometry of molecules containing both benzoyl and carboxymethyl groups on an aromatic heterocyclic core. The reaction is triggered by a dissociative protonation on the heterocyclic ring at the atom (carbon or nitrogen) that bonds to the benzoyl group, leading to an intermediate ion-neutral complex. The incipient benzoyl cation in the complex migrates to attack the carboxyl group of the neutral partner at the carbonyl or hydroxyl oxygen under thermodynamic or kinetic control, respectively. Elimination of benzoic acid followed by loss of carbon monoxide takes place as a result of the transacylation.
ObjectiveThis study was performed to discuss the characteristics, diagnosis, and
treatment of primary prostatic extragastrointestinal stromal tumor
(EGIST).MethodsThe case history data of a patient with an EGIST were analyzed and discussed
with a literature review.ResultsThe patient was diagnosed with a pelvic tumor, possibly malignant. We
ascertained the diagnosis by exploratory surgery and pathological biopsy.
The tumor was present in the prostate and infiltrated and pressed against
the anterior rectal wall. Pathological biopsy showed that the tumor
comprised spindle cells, which were also present at the junction of the
tumor and prostate tissue. Immunohistochemically, the tumor cells were
positive for CD117, DOG-1, CD34, and smooth muscle actin and negative for
S100 and desmin; Ki-67LI was about 10%. These results support the diagnosis
of primary prostatic EGIST.ConclusionThe rarity and nonspecific clinical manifestation of prostatic EGIST
facilitate misdiagnosis. Diagnosis mainly depends on imaging examination and
characteristic histopathological and immunohistochemical features, and GIST
must be excluded. Surgery is the main treatment method, and imatinib is
suggested for unresectable and malignant EGISTs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.